Karnataka

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post : Senior Costing Associate

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.

Nitte (Deemed to be University) established in 2008, has been placed under Category 'A' by the Ministry of Human Resources Development (MHRD), Government of India. It has also been accredited 'A' Grade by the National Assessment and Accreditation Council (NAAC) and ranked 77th by National Institutional Ranking Framework (NIRF), Ministry of Human Resource Development (MHRD), Government of India.

Railway Recruitment Board, initially was known as 'Railway Service Commission' but in January 1985 it was renamed as Railway Recruitment Board. These were the small’s beginnings which is due course developed into a network of railway lines all over the country. By 1880 the Indian Railway system had a route mileage of about 9000 miles. INDIAN RAILWAYS, the premier transport organization of the country is the largest rail network in Asia and the world’s second largest under one management.

The Public Service Commission was constituted under the provisions of the Constitution of India on 18-05-1951. In accordance with the provisions of clause 14 of the Public Service Commission Regulations 1950, the staff of the Public Service Commissioner as it stood on 18-05-1951, was continued as the nucleus of the staff of the Public Service Commission.  The Office of the Central Recruitment Board which was a part of Mysore (Now Karnataka) Government Secretariat followed the Government Secretariat Manual, for office procedures. This was continued even in the office of the Public Service Commissioner and later in the office of the Public Service Commission with necessary notifications to carry out recruitment and conduct of Competitive Examinations, Departmental Examinations etc.

Post : Pharmacist

Manipal Academy of Higher Education is synonymous with excellence in higher education. Over 28,000 students from 57 different nations live, learn and play in the sprawling University town, nestled on a plateau in Karnataka’s Udupi district. It also has nearly 2500 faculty and almost 10000 other support and service staff, who cater to the various professional institutions in health sciences, engineering, management, communication and humanities which dot the Wi-Fi-enabled campus.

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products).